Login to Your Account

Other News To Note

Monday, August 29, 2011
NeuroHealing Pharmaceuticals Inc., of Newton, Mass., received a grant from the Michael J. Fox Foundation for Parkinson's Research to advance the clinical development of NH004, specifically a multicenter, double-blind, placebo-controlled crossover study testing the drug in Parkinson's patients suffering from sialorrhea.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription